Treatment-free remission maintained in 14 of 21 patients who discontinued tyrosine kinase inhibitors.
A retrospective study using a cohort of the ALiCCS Study sought to determine hospitalization risks among survivors of leukemia during childhood 20 years after diagnosis.
A retrospective and prospective study of Italian adult patients with CML investigated the potential for childbearing and outcomes in this patient population.
De-escalation of TKI therapy may be an effective management strategy among patients with CML who have responded to therapy.
In this study, researchers assigned 75 patients with newly diagnosed Philadelphia chromosome (Ph)-positive CML-CP to receive dasatinib 50 mg once daily.